Partners featuring serial innovators building breakthrough science (post–core-science de-risking), providing intensive hands-on backing—weekly partner calls, executive coaching, Tony Robbins entry—and a PhD-heavy technical team.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Invests from nascent-stage through M&A, pairing emerging ventures with 20+ Fortune 500 partners for active product co-development, commercial partnerships, and PE-backed support across regulated sectors like healthcare, finance, and energy. The firm continues to build its presence across the venture capital landscape.
Selective firm investing where it has an unfair advantage, running a company-creation platform with 22 EIRs and a 90+ C-suite council delivering market insights to healthcare, data+AI and cyber defense. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Is dedicated to companies empowering informed, connected health consumers and building system-level resilience to improve outcomes, experiences, and lower healthcare costs. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
Invests in rigorously technical enterprise entrepreneurs (infrastructure, analytics, AI/ML, developer tools, security) with very compact initial checks and repeated follow-on backing, plus think-tank-style technical essays founders utilize as reference.
Co-led by Facebook co-founder Eduardo Saverin, delivers B2B startup ventures structured access to BCG consultants and corporate clients and supports expand across the US and Asia. The firm continues to build its presence across the venture capital landscape.
Uses AI, analytics, and behavioral science to identify silent suffering alongside, via rigorous decision logging, quarterly reviews, supports founders unlock fresh addressable markets. Standing apart by and cognitively diverse PhD-led critique.
